Combining data from various studies, it can be hypothesized that the reduction of RKIP by epigenetic and post-transcriptional mechanisms is a negative prognostic factor while the transition of RKIP from the native to the phosphorylated form could constitute a protective factor against tumour progression, metastasis and death. The gene discussed is PEBP1; the disease is neoplasm.